AR and polycystic ovary syndrome: Although biochemical and mass spectrometry analyses suggest direct interactions between the E3 ligase RNF6 and AR16, there is no report on whether RNF6 modulates proteasome degradation of AR or enhances AR transcriptional activity in an androgen-induced PCOS rat model.